Medicis Settles Investors' Fraud Action For $18M
A putative class of investors reached an $18 million settlement with Medicis Pharmaceutical Corp. on Wednesday, putting to bed an Arizona suit that accused the dermatological drugmaker and several executives of...To view the full article, register now.
Already a subscriber? Click here to view full article